About Us

Chip Amrein

Chip is a life-science commercial expert with 25+ years of experience leading world-class launches in the cardiometabolic therapeutic area.  Chip worked at Merck for 10 years in multiple progressive commercial roles and developed and executed multiple product launches in diabetes and obesity. Chip then spent 15 years at Novo Nordisk where he led new product development for diabetes and obesity products in the US and then moved to Denmark to lead the global commercial launch of Saxenda®.   Chip then returned to the US to lead the insulin portfolio and worked on providing solutions to make insulin more affordable for patients.  Chip also led the launch strategy in the US for digital health solutions to support medication adherence and persistence for diabetes and obesity products.  Chip left Novo Nordisk to become the Senior Vice President of Marketing at Better Therapeutics and was responsible for the launch of AspyreRx®, the first prescription digital therapeutic cleared by the FDA for the treatment of type 2 diabetes. Chip continues to follow his passion for improving care for people with cardiometabolic conditions by being one of the founders of HealthyIQ.

Joachim Becker

Joachim Becker is a seasoned leader in global healthcare strategy, with a career spanning over four decades. Joachim is widely recognized for his transformative work in diabetes care and education, particularly in emerging markets. His expertise in forging public-private partnerships and advancing patient-centered solutions continues to inspire innovation in the field of diabetes management.

During his tenure at Eli Lilly and Company, Joachim served as Senior Advisor for Diabetes Strategy in Emerging Markets. In this capacity, he spearheaded collaborations with governments, payors, providers, and patient organizations across the Gulf region, Sub-Saharan Africa, and South-East Asia. His efforts focused on creating tailored solutions that leveraged the strengths of all stakeholders to slow the progression of diabetes and enhance care delivery.

Joachim’s contributions to Lilly’s diabetes portfolio began in 1999 and included landmark initiatives such as the global rollout of the Diabetes Conversation Maps, an education tool now used in over 130 countries and translated into more than 30 languages. He also played a pivotal role in developing Lilly’s partnerships with organizations like the International Diabetes Federation, the Health Authority of Abu Dhabi, and Project Hope, driving advancements in diabetes education and capacity-building in regions such as China, India, and the Gulf.

Earlier in his career, Joachim held various leadership positions at Lilly, including Managing Director for Lilly Switzerland and Director of New Product Planning at Lilly’s headquarters. His deep understanding of patient behavior and therapeutic area dynamics informed his strategic decisions and established him as a respected authority in the healthcare industry.

A native of Germany, Joachim joined Lilly in 1982 after earning a Master’s Degree in International Business from the University of South Carolina, USA.

Paul Lasiuk

Following a corporate career that included Proctor & Gamble GmbH, Eli Lilly International and Bain & Company, Paul co-founded, built and monetized multiple healthcare enterprises including Healthy Interactions and Medcurrent.  Paul co-founded and invested in and was the CEO of Healthy Interactions.  

Healthy Interactions developed an innovative approach to engaging people with chronic conditions.  Healthy Interactions partnered with over 20 leading global disease associations such as the American Diabetes Association, Diabetes UK, Canadian Diabetes Association and the International Diabetes Federation.  The disease associations’ subject matter experts worked with Healthy Interactions to develop programs that aligned with local clinical guidelines and cultural nuances.  When Healthy Interactions was sold, it had improved over 40 million lives of people with diabetes and other chronic conditions in over 100 countries and in 30 languages.  Healthy Interactions trained, supported and provided tools to over 130,000 licensed healthcare professionals.  There were over 60 independent studies validating the efficacy of the Healthy Interactions programs to improve engagement, care plan commitments, clinical outcomes and related medical expenses.  Healthy Interactions was acquired in 2021.  

Medcurrent developed a clinical decision support software that seamlessly integrates into health system EHRs.  The Medcurrent platform used leading association evidence based rules, pulling patient data from the EHRs to advise healthcare professionals on appropriate radiological panels to order and appropriate clinical lab use.  In so doing, Medcurrent’s platform improves the use of evidence based rules, optimal use of radiology and lab assets.  The use of Medcurrent’s clinical decision support platform improved ordering efficiency, improved the standard of care, and lowered medical expenses.  Medicurrent platforms are in use in 8 countries, including a 40% marketshare in the UK.  Medcurrent was acquired in 2024.  

Paul has other investments, mostly in healthcare related enterprises.  

Paul has degrees from the University of Toronto and The University of Michigan.  He is an avid lifelong hockey player and has completed the Hawaii Ironman race. 

Andrew Leong-Fern

Andrew is a seasoned entrepreneur committed to building innovative businesses that empower individuals to be healthier and purposeful in their pursuits. He is the driving force behind several pioneering ventures:

Founder of Strategy AI: This enterprise equips teams across industries with practical AI solutions and change management tools to accelerate AI adoption and achieve immediate results.

Co-Founder of Healthy Interactions: This diabetes education company delivers unique healthcare professional and patient learning experiences that empower individuals to consciously improve their diabetes care. By enabling consumers to better understand and internalize personally relevant health information, Healthy Interactions has positively influenced 40 million lives in over 100 countries.

Co-Founder of Applied Learning: Focused on the principle that employees make better decisions and adapt their behavior when they quickly internalize and personalize key business information. For over 25 years, hundreds of leading corporations worldwide have leveraged Applied Learning’s Knowledge Map solutions to achieve measurable success.

Andrew’s career began in finance, marketing, and sales roles at IBM and Eli Lilly, spanning multiple countries. He later honed his strategic expertise as a Consultant at Bain & Company.

Andrew holds an MBA from the University of Western Ontario and a Bachelor of Commerce in Finance from the University of Calgary. He credits much of his entrepreneurial acumen to the invaluable lessons learned from his immigrant parents, who demonstrated resilience and innovation in pursuing their own dreams.

Joseph Pepek M.D.

Joseph (Josh) Pepek, M.D. received his Bachelor of Arts degree with honors from Georgetown University. As an undergraduate, he played for Georgetown’s varsity baseball team. Dr. Pepek obtained his medical degree from Georgetown University School of Medicine and served as a United States Navy medical officer. Dr. Pepek completed a surgery internship at Naval Medical Center in San Diego, CA. He then deployed to Iraq with the US Navy Seabees during Operation Iraqi Freedom. He also was the medical officer for the Marine Corps Chemical Biological Incident Response Force in Indian Head, MD. Dr. Pepek then completed his radiation oncology residency at Duke University, where he served as chief resident. He is a radiation oncologist with Astera Cancer Care/Princeton Radiation Oncology and chair of the Department of Radiation Oncology at Penn Medicine Princeton Medical Center in Plainsboro, NJ.